244 related articles for article (PubMed ID: 20086112)
1. Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.
Beuten J; Gelfond JA; Franke JL; Shook S; Johnson-Pais TL; Thompson IM; Leach RJ
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):588-99. PubMed ID: 20086112
[TBL] [Abstract][Full Text] [Related]
2. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.
Rennert H; Zeigler-Johnson CM; Addya K; Finley MJ; Walker AH; Spangler E; Leonard DG; Wein A; Malkowicz SB; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):949-57. PubMed ID: 15824169
[TBL] [Abstract][Full Text] [Related]
3. Association between RNASEL, MSR1, and ELAC2 single nucleotide polymorphisms and gene expression in prostate cancer risk.
Alvarez-Cubero MJ; Pascual-Geler M; Martinez-Gonzalez LJ; Expósito Ruiz M; Saiz M; Cozar JM; Lorente JA
Urol Oncol; 2016 Oct; 34(10):431.e1-8. PubMed ID: 27318894
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.
Nupponen NN; Wallén MJ; Ponciano D; Robbins CM; Tammela TL; Vessella RL; Carpten JD; Visakorpi T
Genes Chromosomes Cancer; 2004 Feb; 39(2):119-25. PubMed ID: 14695991
[TBL] [Abstract][Full Text] [Related]
5. Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.
Robbins CM; Hernandez W; Ahaghotu C; Bennett J; Hoke G; Mason T; Pettaway CA; Vijayakumar S; Weinrich S; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD; Kittles RA
Prostate; 2008 Dec; 68(16):1790-7. PubMed ID: 18767027
[TBL] [Abstract][Full Text] [Related]
6. Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma.
Noonan-Wheeler FC; Wu W; Roehl KA; Klim A; Haugen J; Suarez BK; Kibel AS
Prostate; 2006 Jan; 66(1):49-56. PubMed ID: 16114055
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of the principal genes related to prostate cancer: a review.
Alvarez-Cubero MJ; Saiz M; Martinez-Gonzalez LJ; Alvarez JC; Lorente JA; Cozar JM
Urol Oncol; 2013 Nov; 31(8):1419-29. PubMed ID: 23141781
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of genetic biomarkers in clinical progression of prostate cancer.
Alvarez-Cubero MJ; Martinez-Gonzalez LJ; Saiz M; Carmona-Saez P; Alvarez JC; Pascual-Geler M; Lorente JA; Cozar JM
Exp Mol Med; 2015 Aug; 47(8):e176. PubMed ID: 26251261
[TBL] [Abstract][Full Text] [Related]
9. Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans.
Shook SJ; Beuten J; Torkko KC; Johnson-Pais TL; Troyer DA; Thompson IM; Leach RJ
Clin Cancer Res; 2007 Oct; 13(19):5959-64. PubMed ID: 17908993
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the RNASEL/HPC1, and macrophage scavenger receptor 1 in Asian-Indian advanced prostate cancer.
Rennert H; Zeigler-Johnson C; Mittal RD; Tan YC; Sadowl CM; Edwards J; Finley MJ; Mandhani A; Mital B; Rebbeck TR
Urology; 2008 Aug; 72(2):456-60. PubMed ID: 18436282
[TBL] [Abstract][Full Text] [Related]
11. MSR1 variants and the risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.
Hsing AW; Sakoda LC; Chen J; Chokkalingam AP; Sesterhenn I; Gao YT; Xu J; Zheng SL
Carcinogenesis; 2007 Dec; 28(12):2530-6. PubMed ID: 17768178
[TBL] [Abstract][Full Text] [Related]
12. Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene.
Maier C; Haeusler J; Herkommer K; Vesovic Z; Hoegel J; Vogel W; Paiss T
Br J Cancer; 2005 Mar; 92(6):1159-64. PubMed ID: 15714208
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer susceptibility genes: lessons learned and challenges posed.
Simard J; Dumont M; Labuda D; Sinnett D; Meloche C; El-Alfy M; Berger L; Lees E; Labrie F; Tavtigian SV
Endocr Relat Cancer; 2003 Jun; 10(2):225-59. PubMed ID: 12790786
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
Xu J; Zheng SL; Carpten JD; Nupponen NN; Robbins CM; Mestre J; Moses TY; Faith DA; Kelly BD; Isaacs SD; Wiley KE; Ewing CM; Bujnovszky P; Chang B; Bailey-Wilson J; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
Am J Hum Genet; 2001 Apr; 68(4):901-11. PubMed ID: 11254448
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the RNAse L gene in prostate cancer.
Kieffer N; Schmitz M; Scheiden R; Nathan M; Faber JC
Bull Soc Sci Med Grand Duche Luxemb; 2006; (1):21-8. PubMed ID: 16869093
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study.
Fesinmeyer MD; Kwon EM; Fu R; Ostrander EA; Stanford JL
Prostate; 2011 Oct; 71(14):1538-47. PubMed ID: 21360564
[TBL] [Abstract][Full Text] [Related]
17. DNA variation in MSR1, RNASEL and E-cadherin genes and prostate cancer in Poland.
Cybulski C; Wokołorczyk D; Jakubowska A; Gliniewicz B; Sikorski A; Huzarski T; Debniak T; Narod SA; Lubiński J
Urol Int; 2007; 79(1):44-9. PubMed ID: 17627168
[TBL] [Abstract][Full Text] [Related]
18. Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up Study.
Chen YC; Giovannucci E; Kraft P; J Hunter D
Carcinogenesis; 2008 May; 29(5):999-1004. PubMed ID: 18375959
[TBL] [Abstract][Full Text] [Related]
19. Association between genetic polymorphisms of macrophage scavenger receptor 1 gene and risk of prostate cancer in the health professionals follow-up study.
Chen YC; Giovannucci E; Kraft P; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):1001-3. PubMed ID: 18398045
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1.
Lange EM; Gillanders EM; Davis CC; Brown WM; Campbell JK; Jones M; Gildea D; Riedesel E; Albertus J; Freas-Lutz D; Markey C; Giri V; Dimmer JB; Montie JE; Trent JM; Cooney KA
Prostate; 2003 Dec; 57(4):326-34. PubMed ID: 14601029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
